Page last updated: 2024-11-01

nimodipine and Axonal Injury, Diffuse

nimodipine has been researched along with Axonal Injury, Diffuse in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winkler, T1
Sharma, HS1
Stålberg, E1
Badgaiyan, RD1
Gordh, T1
Westman, J1
Tubbs, RS1
Shoja, MM1
Jamshidi, M1
Shokouhi, G1

Other Studies

2 other studies available for nimodipine and Axonal Injury, Diffuse

ArticleYear
An L-type calcium channel blocker, nimodipine influences trauma induced spinal cord conduction and axonal injury in the rat.
    Acta neurochirurgica. Supplement, 2003, Volume: 86

    Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Diffuse Axonal Injury; Edema; Evoked Po

2003
Does the neuroprotective agent erythropoietin amplify diffuse axonal injury in its early stages?
    Medical hypotheses, 2007, Volume: 69, Issue:6

    Topics: Animals; Axons; Brain; Calcium; Calcium Channels; Cell Proliferation; Diffuse Axonal Injury; Erythro

2007